Tourette Syndrome Clinical Trials

Find Tourette Syndrome Clinical Trials Near You

Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Tourette Syndrome (TS) children were administered Pei Tu Ning Feng Tang treatment. The differences in gut microbiota composition, peripheral blood stress hormones, oxidative stress markers, cytokines, neurotransmitters, and hair cortisol concentrations were observed before and after treatment. Combined with the differences in tic-like behavioral indicators, the therapeutic efficacy of Pei Tu Ning Feng Tang was evaluated. Additionally, TS children underwent two fNIRS examinations before and after treatment to quantitatively describe the activation of brain function by Pei Tu Ning Feng Tang and to investigate its neural mechanisms against tics. Scores were assessed before and after treatment using the Yale Global Tic Severity Scale (YGTSS) and the Traditional Chinese Medicine Syndrome Score Sheet for Pediatric Tourette Syndrome (Spleen Deficiency and Liver Hyperactivity Type) to observe the efficacy of the medication.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Maximum Age: 15
Healthy Volunteers: f
Locations
Other Locations
China
Dongdong Qin
RECRUITING
Dali
Contact Information
Primary
Dongdong Qin Qin, Doctor
qindong108@163.com
+86 13888304863
Time Frame
Start Date: 2026-04-01
Estimated Completion Date: 2027-07
Participants
Target number of participants: 60
Treatments
Experimental: Tourette Syndrome (TS) children were administered Pei Tu Ning Feng Tang treatment.
The differences in gut microbiota composition, peripheral blood stress hormones, oxidative stress markers, cytokines, neurotransmitters, and hair cortisol concentrations were observed before and after treatment.
Sponsors
Leads: Dongdong Qin

This content was sourced from clinicaltrials.gov